EGFR and lung adenocarcinoma: The frequency of EGFR mutations vary according to the population; in Caucasians EGFR mutations occurs in 10 to 15%, whereas in East Asia and Latin America these are more frequent occurring in 30 to 50% of lung adenocarcinoma patients [4–6].